Ocular Therapeutix Inc.
OCUL | NASDAQ
$6.75
-$0.22 (-3.16%)
Nov 2, 2026, 2:35 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -78.76M | -88.61M | -64.65M | -69.42M | -67.81M | -64.05M | -48.39M | -36.49M | -43.78M | -64.85M | -29.22M | -516K | -20.68M | -30.32M | -15.54M | -24.19M | -18.77M | -12.54M | -3.85M | 2.66M | -8.48M | 3.12M |
Depreciation & Amortization | 1.85M | 1.28M | 1.25M | 1.07M | 1.03M | 981K | 951K | 959K | 956K | 920K | 958K | 890K | 652K | 483K | 491K | 509K | 552K | 557K | 570K | 594K | 611K | 646K |
Stock-Based Compensation | 14.65M | 15.58M | 11.36M | 11.69M | 9.68M | 10.46M | 7.2M | 6.64M | 11.29M | 7.98M | 4.33M | 4.51M | 4.41M | 4.57M | 4.23M | 4.24M | 4.28M | 4.21M | 3.84M | 3.76M | 4.29M | 3.09M |
Other Working Capital | 847K | -8.89M | -790K | 5.81M | 3.78M | -1.41M | 3.53M | -1.65M | 9.21M | -14.06M | -4.57M | 2.31M | 2.89M | -3.43M | 939K | 1.97M | 1.74M | -1.76M | 215K | 3.44M | 1.13M | -550K |
Other Non-Cash Items | -49K | 4.79M | -100K | 2.21M | 1.32M | 2.41M | -47K | -6.46M | 3.6M | 35.07M | 8.03M | -24.02M | 1.25M | 7.79M | -4.01M | 2.36M | -1.57M | -5.77M | -14.68M | -22.68M | -12.25M | 1.13M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.13M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25.02M |
Change in Working Capital | -4.96M | 962K | -2.1M | 3.73M | 552K | 5.53M | 858K | -1.21M | 3.13M | -13.01M | -6.55M | 6.22M | -4.58M | -2.5M | -2.14M | 3.91M | 4.63M | -5.05M | -1.03M | 2.69M | -4.23M | -328K |
Operating Cash Flow | -67.27M | -65.99M | -54.25M | -50.73M | -55.24M | -44.67M | -39.43M | -36.56M | -24.8M | -33.89M | -22.45M | -12.92M | -20.08M | -19.97M | -16.96M | -13.17M | -10.88M | -18.6M | -15.15M | -12.98M | -20.06M | -17.36M |
Capital Expenditures | -3.37M | -4.66M | -2.84M | -5.99M | -1.25M | -1.93M | -202K | -89K | -742K | -255K | -459K | -259K | -1.99M | -3.38M | -2.15M | -794K | -495K | -276K | -631K | -276K | -129K | -158K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 130K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -3.37M | -4.66M | -2.84M | -5.99M | -1.12M | -1.93M | -202K | -89K | -742K | -255K | -459K | -259K | -1.99M | -3.38M | -2.15M | -794K | -495K | -276K | -631K | -276K | -129K | -158K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -26.13M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.64M | -2.08M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -275K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | 4.18M | 3.99M | 4.18M | 1.7M | 4.87M | 441K | 82.47M | 821K | 78K | 458K | 374K | 493K | 129K | n/a | 679K | 1.03M | -1K |
Financial Cash Flow | 2.58M | 294K | 449.38M | 10.36M | 97.81M | 4.18M | 4.51M | 4.18M | 2.2M | 321.22M | 108.17M | 57.12M | 9.65M | 78K | 458K | 374K | 493K | 129K | 667K | 679K | 2.67M | -1.16M |
Net Cash Flow | -68.06M | -70.36M | 392.29M | -46.36M | 41.45M | -42.42M | -35.12M | -32.47M | -23.35M | 287.08M | 85.26M | 43.94M | -12.42M | -23.27M | -18.65M | -13.59M | -10.88M | -18.75M | -15.12M | -12.58M | -17.52M | -18.68M |
Free Cash Flow | -70.64M | -70.66M | -57.09M | -56.72M | -56.48M | -46.6M | -39.63M | -36.65M | -25.54M | -34.14M | -22.91M | -13.18M | -22.07M | -23.35M | -19.11M | -13.96M | -11.37M | -18.88M | -15.78M | -13.26M | -20.19M | -17.52M |
Adj. Free Cash Flow | -85.29M | -86.24M | -68.45M | -68.41M | -66.16M | -57.06M | -46.83M | -43.29M | -36.84M | -42.12M | -27.24M | -17.69M | -26.48M | -27.92M | -23.34M | -18.2M | -15.65M | -23.09M | -19.63M | -17.02M | -24.48M | -20.6M |
Maintenance CapEx | -1.85M | -1.28M | -2.84M | -5.99M | -1.25M | -1.93M | n/a | n/a | -198.69K | n/a | -55.89K | n/a | -368.67K | -3.28M | -930.7K | -794K | -116.86K | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | -1.52M | -3.38M | n/a | n/a | n/a | n/a | -202K | -89K | -543.32K | -255K | -403.11K | -259K | -1.62M | -103.83K | -1.22M | n/a | -378.14K | -276K | -631K | -276K | -129K | -158K |
Owner Earnings | -69.12M | -67.28M | -57.09M | -56.72M | -56.48M | -46.6M | -39.43M | -36.56M | -25M | -33.89M | -22.51M | -12.92M | -20.44M | -23.25M | -17.89M | -13.96M | -10.99M | -18.6M | -15.15M | -12.98M | -20.06M | -17.36M |
Add to Watchlist
Select watchlists to add or remove OCUL